Mycophenolate Mofetil

Clinical efficacy of azathioprine replaced with mycophenolate mofetil in renal transplant recipients

肾移植术后吗替麦考酚酯替换硫唑嘌呤的临床分析

GVHD prophylaxis regimen consisted of cyclosporine ( CsA ) and mycophenolate mofetil ( MMF ).

移植物抗宿主病(GVHD) 的预防采用环孢菌素A ( csa ) +霉酚酸酯 ( MMF ) 方案.

Of them a 45 year old male recipient with tuberculous contracted bladder underwent cutaneous ureterostomy as kidney transplantation was conducted and then received immunosuppressive therapy of zenapax+ tacrolimus ( FK506)+ mycophenolate mofetil ( MMF)+ steroid ( Pred).

结核性膀胱挛缩1例，45岁，行肾移植加移植肾输尿管皮肤造口术，免疫抑制方案为赛尼哌（Zenapax）+他克莫司（FK506）+霉酚酸酯（MMF）+泼尼松（Pred）；

Objective To evaluate the efficacy of mycophenolate Mofetil ( MMF) and azathioprine ( AZA) after renal transplantation.

目的客观评价肾移植术后骁悉（mycohpenolatemofetil，MMF）与硫唑嘌呤（azathioprine，AZA）抗排斥反应效果的差别。

Comparison of clinical therapeutic effects of mycophenolate mofetil and azathioprine in patients after renal transplantation

肾移植病人应用霉酚酸酯与硫唑嘌呤的临床疗效比较